Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistence of ex vivo expanded tumour and pathogen specific T-cells after allogeneic stem cell transplant for myeloid malignancies (the INTACT study).
Jiang W, Avdic S, Lee KH, Street J, Castellano-González G, Simms R, Clancy LE, Blennerhassett R, Patrick E, Chan AS, McGuire HM, Myers N, Gloss BS, Gabriel M, Bateman CM, Micklethwaite K, Gottlieb DJ, Blyth E. Jiang W, et al. Among authors: patrick e. Leukemia. 2023 Nov;37(11):2330-2333. doi: 10.1038/s41375-023-02033-5. Epub 2023 Sep 15. Leukemia. 2023. PMID: 37714926 No abstract available.
Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV-specific T cells.
McGuire HM, Rizzetto S, Withers BP, Clancy LE, Avdic S, Stern L, Patrick E, Fazekas de St Groth B, Slobedman B, Gottlieb DJ, Luciani F, Blyth E. McGuire HM, et al. Among authors: patrick e. Clin Transl Immunology. 2020 Jul 2;9(7):e1149. doi: 10.1002/cti2.1149. eCollection 2020. Clin Transl Immunology. 2020. PMID: 32642063 Free PMC article.
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.
Jiang W, Clancy LE, Avdic S, Sutrave G, Street J, Simms R, McGuire HM, Patrick E, Chan AS, McCaughan G, Myers N, Micklethwaite KP, Antonenas V, Selim AG, Ritchie D, Bateman CM, Shaw PJ, Blyth E, Gottlieb DJ. Jiang W, et al. Among authors: patrick e. Blood Adv. 2022 Sep 13;6(17):4949-4966. doi: 10.1182/bloodadvances.2022007103. Blood Adv. 2022. PMID: 35819448 Free PMC article.
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease.
Kott KA, Chan AS, Vernon ST, Hansen T, Kim T, de Dreu M, Gunasegaran B, Murphy AJ, Patrick E, Psaltis PJ, Grieve SM, Yang JY, Fazekas de St Groth B, McGuire HM, Figtree GA. Kott KA, et al. Among authors: patrick e. Clin Transl Immunology. 2023 Nov 2;12(11):e1462. doi: 10.1002/cti2.1462. eCollection 2023. Clin Transl Immunology. 2023. PMID: 37927302 Free PMC article.
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review.
Figtree GA, Vernon ST, Harmer JA, Gray MP, Arnott C, Bachour E, Barsha G, Brieger D, Brown A, Celermajer DS, Channon KM, Chew NWS, Chong JJH, Chow CK, Cistulli PA, Ellinor PT, Grieve SM, Guzik TJ, Hagström E, Jenkins A, Jennings G, Keech AC, Kott KA, Kritharides L, Mamas MA, Mehran R, Meikle PJ, Natarajan P, Negishi K, O'Sullivan J, Patel S, Psaltis PJ, Redfern J, Steg PG, Sullivan DR, Sundström J, Vogel B, Wilson A, Wong D, Bhatt DL, Kovacic JC, Nicholls SJ; CRE for CAD Collaborators. Figtree GA, et al. J Am Coll Cardiol. 2023 Sep 26;82(13):1343-1359. doi: 10.1016/j.jacc.2023.06.045. J Am Coll Cardiol. 2023. PMID: 37730292 Free PMC article. Review.
Thinking process templates for constructing data stories with SCDNEY.
Cao Y, Tran A, Kim H, Robertson N, Lin Y, Torkel M, Yang P, Patrick E, Ghazanfar S, Yang J. Cao Y, et al. Among authors: patrick e. F1000Res. 2023 Dec 15;12:261. doi: 10.12688/f1000research.130623.1. eCollection 2023. F1000Res. 2023. PMID: 38434622 Free PMC article.
194 results